Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05784714 · ClinicalTrials.gov registry record · NA
NOLA GEM: Feasibility and Acceptability of an MHealth Intervention for Violence-affected PLWH
A NA study of HIV and Substance Use, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 4
- Study locations
NCT05784714: Completed NA study of HIV and Substance Use, sponsored by Tulane University.
NCT05784714 is a NA study of HIV and Substance Use that has completed, run by Tulane University. The registered enrollment target is 32 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05784714, a NA study of HIV and Substance Use, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of the proposed research is to conduct formative work to develop, pilot and refine a smartphone delivered intervention for violence affected people living with HIV utilizing a novel spatial-temporal methodology, geographical ecological momentary assessment (GEMA), to first identify the activity spaces and daily psychosocial experiences (mental health symptoms, substance use, self-efficacy, coping) impacting adherence and viral suppression, and apply them to intervention. Guided by an ecological perspective, the investigators will adapt Living in the Face of Trauma to a mobile platform with GEMA informed intervention targets. The resulting app shall be referred to as NOLA GEM. Our long-term goal is delivering accessible interventions informed by daily experiences that affect health for PLWH. The investigators will test feasibility, acceptability and preliminary efficacy of the GEMA-informed NOLA GEM app against GEMA alone on adherence and care, and secondary outcomes of mental health and substance use.
Primary Outcome
Self report taking all HIV-related medication and treatment in past 30 days
Conditions Studied
Interventions
- BEHAVIORAL NOLA GEM
Study Locations (4)
Louisiana
- Access Health Louisiana - New Orleans
- Women With A Vision - New Orleans
- CrescentCare - New Orleans
- Institute of Women & Ethnic Studies - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT05784714 record still lists
NCT05784714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which NOLA GEM is the first listed.
NCT05784714 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05784714 about?
NCT05784714 is a clinical study titled "NOLA GEM: Feasibility and Acceptability of an MHealth Intervention for Violence-affected PLWH". The objective of the proposed research is to conduct formative work to develop, pilot and refine a smartphone delivered intervention for violence affected people living with HIV utilizing a novel spatial-temporal methodology, geographical ecological momentary assessment (GEMA), to first identify the...
What is the current status of trial NCT05784714?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-07-14. Estimated completion is 2024-11-30.
What conditions does trial NCT05784714 study?
This clinical trial studies the following conditions: HIV, Substance Use, Mental Health.
What interventions are being tested in trial NCT05784714?
The interventions under investigation include: NOLA GEM (BEHAVIORAL).
Who is sponsoring clinical trial NCT05784714?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05784714 being conducted?
This trial has 4 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05784714's enrollment target sits among peer trials
32 260th of 303 higher than 42 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI